发明名称 1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUORO-4-(1-METHYL- 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-UREA AND RELATED COMPOUNDS AND THEIR USE IN THERAPY
摘要 PROBLEM TO BE SOLVED: To provide alternative compounds which provide unexpected activity (e.g., activity against mutant RAS cancer) as compared to one or more of structurally-related known compounds.SOLUTION: This invention provides compounds of the formula (I) which, inter alia, are useful in the treatment of cancer, e.g., cancer characterized by (e.g., driven by) mutant RAS ("mutant RAS cancer").
申请公布号 JP2015180675(A) 申请公布日期 2015.10.15
申请号 JP20150115366 申请日期 2015.06.08
申请人 CANCER RESEARCH TECHNOLOGY LTD;INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL:THE 发明人 CAROLINE SPRINGER;ION NICULESCU-DUVAZ;RICHARD MARAIS;DAN NICULESCU-DUVAZ;ALFONSO ZAMBON;DELPHINE MENARD
分类号 C07D471/04;A61K31/437;A61P35/00;A61P35/02 主分类号 C07D471/04
代理机构 代理人
主权项
地址